Cepmox
$ 41,00 – $ 115,00Price range: $ 41,00 through $ 115,00
Cernos Gel
$ 48,00 – $ 120,00Price range: $ 48,00 through $ 120,00
Cerecetam
$ 58,00 – $ 255,00Price range: $ 58,00 through $ 255,00
Cerecetam is a well-regarded nootropic medication designed to support and enhance essential cognitive functions. The formula works by optimizing the metabolic processes within brain cells to improve communication between the cerebral hemispheres. It is primarily used to boost memory, concentration, and mental clarity in individuals facing cognitive challenges. Furthermore, Cerecetam is an effective option for managing cortical myoclonus by reducing involuntary muscle movements. This reliable treatment helps maintain overall neurological health and promotes consistent daily brain performance.
Active substance: Piracetam
SKU:
Cerecetam
Categories: AntiConvulsants, Dementias
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Cerecetam belongs to a group of agents often categorized as racetam-derivative nootropics, with piracetam serving as its primary active pharmaceutical ingredient. It is structurally related to gamma-aminobutyric acid (GABA) and is utilized in international clinical settings for cognitive support, cerebrovascular conditions, and cortical myoclonus. In the United States, Cerecetam is not approved by the Food and Drug Administration (FDA) and is dispensed in accordance with applicable federal and state regulations.
Clinical evaluation by a licensed healthcare provider is necessary prior to considering therapy with racetam derivatives to assess therapeutic appropriateness, baseline renal function, and risk of drug interactions. Understanding its absorption parameters, target receptor modulation, and safety profile ensures appropriate patient management.
| Attribute | Specification |
|---|---|
| Active ingredient (INN) | Piracetam |
| Therapeutic class | Pyrrolidone-derivative nootropic agent |
| Dosage form | Oral tablets / hard capsules |
| Route of administration | Oral |
| Primary purpose | Cortical myoclonus management and cognitive symptom support (international) |
| Prescription status | Dispensed in accordance with applicable federal and state regulations |
Pharmacological Profile and Clinical Applications
How the drug works
The mechanism of action of Cerecetam involves neuronal and vascular pathways without acting as a direct central nervous system stimulant or sedative. At the cellular level, the active substance interacts with membrane phospholipids, restoring neuronal membrane fluidity and improving macromolecular functional integrity. Pharmacological investigations indicate that it enhances cholinergic neurotransmission by modulating post-synaptic acetylcholine receptor density and sensitivity. Additionally, it positively modulates AMPA-type glutamate receptors, supporting synaptic plasticity involved in memory formation. From a vascular standpoint, Cerecetam improves microcirculation by reducing erythrocyte adhesion to vascular endothelium, decreasing blood viscosity, and inhibiting platelet aggregation. It also increases cerebral glucose utilization and oxygen consumption in hypoxemic or ischemic neuronal tissues.
Main uses
In jurisdictions where approved, Cerecetam is indicated primarily as an adjunctive treatment for cortical myoclonus of vascular or neurodegenerative origin. It is also prescribed for symptomatic management of age-associated cognitive decline, post-stroke psycho-organic syndrome, and vascular vertigo. Any use of Cerecetam within the United States for memory enhancement, cerebrovascular insufficiency, or neuroprotection is considered off-label and lacks formal FDA evaluation for safety and efficacy. Prescribers must evaluate off-label applications carefully against established evidence-based alternatives before initiating therapy.
How it’s absorbed and eliminated
Pharmacokinetic studies demonstrate that oral doses of Cerecetam are rapidly and almost completely absorbed from the gastrointestinal tract. Peak plasma concentration (Cmax) is achieved within approximately 0.5 to 1.5 hours in fasting conditions. Absolute bioavailability approaches 100%. The active compound does not bind significantly to plasma proteins and distributes widely throughout body tissues, readily crossing the blood-brain barrier as well as the placental barrier. The elimination half-life (t1/2) in human plasma is approximately 5 hours, whereas its clearance from cerebrospinal fluid is slower, with a half-life of roughly 8.5 hours. Excretion occurs predominantly via the renal system, with more than 90% of the administered dose excreted unchanged in urine within 30 hours through glomerular filtration.
Dosing schedule
Dosing parameters for Cerecetam vary based on clinical indication and individual patient clearance. For cortical myoclonus, standard international titration schedules begin at 7.2 g per day in divided doses, increasing by 4.8 g every 3 to 4 days up to a maximum daily dose of 24 g, administered in 2 or 3 equal portions. For cognitive impairment indications, daily doses generally range between 2.4 g and 4.8 g divided into two or three administrations. Renal dose adjustments are mandatory: patients with mild renal impairment (creatinine clearance 50–79 mL/min) require two-thirds of the standard dose; moderate impairment (30–49 mL/min) requires one-third of the standard dose; severe renal impairment (less than 30 mL/min) requires one-sixth of the standard dose. It is contraindicated in end-stage renal disease (CrCl less than 15 mL/min).
Safety Profile, Precautions, and Interactions
Adverse reactions
Clinical trials and post-marketing surveillance indicate that Cerecetam is generally well tolerated, though adverse reactions occur in a subset of patients. Central nervous system effects include hyperkinesia (nervous movement), nervousness, insomnia, somnolence, depression, and ataxia. Gastrointestinal disturbances such as nausea, diarrhea, vomiting, and upper abdominal pain are reported occasionally. Vascular and metabolic adverse events include weight gain, mild hypotension, and asthenia. Dermatological reactions, including hypersensitivity rash, pruritus, and urticaria, have also been documented.
Important precautions
Special precautions are required in individuals with compromised renal clearance, severe hepatic dysfunction, or a history of hemorrhagic disorders. Because Cerecetam inhibits platelet aggregation, caution is warranted in patients undergoing major surgical procedures or those with active gastrointestinal ulceration. Cerecetam crosses the placental barrier and is excreted into human breast milk; therefore, its use during pregnancy and lactation is not recommended unless clinically indispensable. Elderly patients require routine monitoring of renal function during long-term therapy to prevent drug accumulation.
Compatibility with other medicines
Drug interactions with Cerecetam primarily involve agents affecting coagulation and endocrine function. Co-administration with thyroid extracts (T3 and T4) may cause confusion, irritability, and sleep disturbances due to potential synergistic central effects. Concurrent use with anticoagulants (such as warfarin) or antiplatelet agents (such as aspirin or clopidogrel) enhances the risk of bleeding due to cumulative antiplatelet activity. No significant interactions have been observed with cytochrome P450 enzymes, as piracetam does not undergo hepatic metabolic transformation.
Food and alcohol interactions
Cerecetam may be ingested independently of meals, as food slightly delays the rate of absorption without decreasing total systemic exposure. Simultaneous intake of ethanol with Cerecetam is not recommended; alcohol can intensify central nervous system side effects such as sedation, dizziness, or impaired motor coordination.
Red flags
Immediate medical evaluation is warranted if a patient exhibits signs of severe systemic hypersensitivity, including angioedema (swelling of the face, lips, tongue, or throat) or severe cutaneous blistering. Emergency medical care should also be sought upon emergence of active bleeding events, unexplained bruising, severe confusion, acute hallucinations, or sudden onset of motor impairment.
If you skip a dose
If a dose is missed, it should be taken as soon as remembered unless the timing is close to the subsequent scheduled dose. Patients should not double the dose to compensate for the skipped tablet, as elevated peak concentrations may increase the risk of central nervous system excitability or gastrointestinal adverse effects.
Storage and expiration
Cerecetam tablets and capsules should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication must be kept in its original moisture-resistant packaging, shielded from direct heat and light, and kept securely out of reach of children and domestic animals. Expired products should be disposed of in accordance with local pharmaceutical waste protocols.
Common questions
How does renal function influence Cerecetam clearance?
Because Cerecetam is excreted unchanged by the kidneys via glomerular filtration, reduced renal clearance leads to drug accumulation and potential toxicity. Physicians adjust dosing frequency or dosage amounts based on calculated creatinine clearance values.
Can Cerecetam be stopped abruptly after prolonged use?
Abrupt withdrawal of Cerecetam in patients treated for cortical myoclonus may trigger sudden relapse or myoclonic seizures. Gradual dose reduction under medical supervision is recommended when discontinuing treatment.
Is driving permitted during treatment with Cerecetam?
Cerecetam may cause somnolence, hyperkinesia, or dizziness in sensitive individuals. Operating machinery or driving motor vehicles should be avoided until individual tolerance and cognitive response to the drug are established.
What occurs if Cerecetam is taken alongside blood thinners?
Combining Cerecetam with antiplatelet drugs or oral anticoagulants increases antiplatelet effects, which elevates the risk of severe bleeding. Frequent monitoring of coagulation parameters is required if co-administration is clinically unavoidable.
Is Cerecetam considered a controlled substance in the United States?
Cerecetam is not listed on federal controlled substance schedules; however, it remains an unapproved drug product under FDA regulations and must be handled in compliance with federal and state laws.
In accordance with FDA requirements and federal regulations.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
400 mg ,800 mg ,1200 mg |
|---|---|
| Package |
60 pills ,60 tabs ,90 pills ,120 tabs ,180 tabs ,270 tabs |
| Ενεργός Ουσία |
Related products
Azilect
$ 17,00 – $ 46,00Price range: $ 17,00 through $ 46,00
Active substance: Rasagiline
More Details
This product has multiple variants. The options may be chosen on the product page
Compazine
$ 40,00 – $ 118,00Price range: $ 40,00 through $ 118,00
Active substance: Prochlorperazine
More Details
This product has multiple variants. The options may be chosen on the product page
Dostinex
$ 114,00 – $ 362,00Price range: $ 114,00 through $ 362,00
Active substance: Cabergoline
More Details
This product has multiple variants. The options may be chosen on the product page
Galantamine
$ 70,00 – $ 683,00Price range: $ 70,00 through $ 683,00
More Details
This product has multiple variants. The options may be chosen on the product page
Kemadrin
$ 41,00 – $ 281,00Price range: $ 41,00 through $ 281,00
Active substance: procyclidine
More Details
This product has multiple variants. The options may be chosen on the product page
Lamictal
$ 47,00 – $ 491,00Price range: $ 47,00 through $ 491,00
Active substance: Lamotrigine
More Details
This product has multiple variants. The options may be chosen on the product page
Symmetrel
$ 47,00 – $ 306,00Price range: $ 47,00 through $ 306,00
Active substance: Amantadine
More Details
This product has multiple variants. The options may be chosen on the product page
Topamax
$ 39,00 – $ 584,00Price range: $ 39,00 through $ 584,00
Active substance: Topiramate
More Details
This product has multiple variants. The options may be chosen on the product page
